Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MT1E - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
PAXBP1-AS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
TAS2R45 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors
CA3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LOC101930400 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GDPD2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CTBP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TTLL7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DMRTC1B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ATP8B5P - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM110B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ANKRD65 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FBRSL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RANBP17 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on